Viewing data from:

DIPYRIDAMOLE

ANDA

DIPYRIDAMOLE | A074939 | CHARTWELL INJECTABLES LLC

1 strength0 unique patents0 unique exclusivities

Medicare Part B Spending

CMS physician-administered drug spending for Dipyridamole (2023)

Total Spending

$326K

Total Claims

18,627

Beneficiaries

18,498

ASP Price

—

HCPCS: J1245 — Injection, dipyridamole, per 10 mg

Source: CMS Medicare Part B Spending by Drug (2023). Shows physician-administered drug costs.

API Supply Chain8 active DMFs10 inactive

8 active API suppliers hold Drug Master Files for this ingredient.

SOCIETA ITALIANA MEDICINALI SCANDICCI SIMS SRLDIPYRIDAMOLE

DMF 32091978

AGC PHARMA CHEMICALS EUROPE SLUDIPYRIDAMOLE

DMF 138701998

ORCHID PHARMA LTDDIPYRIDAMOLE

DMF 204162007

MATRIX PHARMACORP PRIVATE LTDDIPYRIDAMOLE USP

DMF 244412010

ALIVUS LIFE SCIENCES LTDDIPYRIDAMOLE USP

DMF 290202015

COHANCE LIFESCIENCES LTDDIPYRIDAMOLE USP

DMF 297452015

QIDONG DONGYUE PHARMACEUTICAL CO LTDDIPYRIDAMOLE

DMF 349952020

SOLARA ACTIVE PHARMA SCIENCES LTDDIPYRIDAMOLE USP

DMF 350452020

ERREGIERRE SPAInactiveDIPYRIDAMOLE

DMF 34891979

INDUSTRIE CHIMICHE FARMACEUTICHE ITALIANE SPAInactiveDIPYRIDAMOLE

DMF 35591979

SA AJINOMOTO OMNICHEM NVInactiveDIPYRIDAMOLE

DMF 38671980

RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPAInactiveDIPYRIDAMOLE

DMF 40161980

SHANGHAI NO 6 PHARMACEUTICAL FACTORYInactiveDIPYRIDAMOLE

DMF 59171985

MEDICHEM SAInactiveDIPYRIDAMOLE

DMF 63171986

LISAC SAInactiveDIPYRIDAMOLE

DMF 79051989

OMNICHEM NVInactiveDIPYRIDAMOLE USP

DMF 148862000

BOEHRINGER INGELHEIM LABSO CHIMIE FINEInactiveDIPYRIDAMOLE

DMF 227642009

YABAO PHARMACEUTICAL GROUP CO LTDInactiveDIPYRIDAMOLE USP

DMF 285662014

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 5MG/ML

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Apr 13, 1998

No patent or exclusivity listings for this strength.